4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-043973
Chief Accounting Officer sold 4,588 shares at $31.19 ($143,100)
- Chief Accounting Officer acquired 4,588 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-21 | Option exercise 10b5-1 | +3,755 | $8.27 | $31,054 | 8,887 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-21 | Option exercise 10b5-1 | +833 | $11.35 | $9,455 | 9,720 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-21 | Sale 10b5-1 | −4,588 | $31.19 | $143,100 | 5,132 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-21 | Option exercise · Stock option (right to buy) 10b5-1 | −3,755 | 0 | D | ||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-21 | Option exercise · Stock option (right to buy) 10b5-1 | −833 | 64,167 | D | ||
| Open-market sales · 4,588 sh · avg $31.19 · $143,100 | |||||||
Loading xslF345X05/ownership.xml…